SEARCH

SEARCH BY CITATION

REFERENCES

  • Adams CWM, Tuqan NA. 1961. The histochemical demonstration of protease by a gelatin-silver film substrate. Nature 189: 469472.
  • Anderson IC, Shipp M, Docherty AJP, Teicher BA. 1996. Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res 56: 715718.
  • Aszodi A, Bateman JF, Gustafsson E, Boot-Handford R, Fassler R. 2000. Mammalian skeletogenesis and extracellular matrix: what can we learn from knockout mice? Cell Struct Funct 25: 7384.
  • Butler G, Hutton M, Wattam BA, Williamson RA, Knauper V, Willenbrock F, Murphy G. 1999. The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations. J Biol Chem 274: 2039120396.
  • Carlevaro MF, Cermelli S, Cancedda R, Cancedda FD. 2000. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113: 5969.
  • Cole AA, Cole MB Jr. 1989. Are perivascular cells in cartilage canals chondrocytes? J Anat 165: 18
  • Cole AA, Wezeman FH. 1985. Perivascular cells in cartilage canals of the developing mouse epiphysis. Am J Anat 174: 119129
  • Cole AA, Wezeman FH. 1987a. Cytochemical localization of tartrate-resistant acid phosphatase, alkaline phosphatase, and nonspecific esterase in perivascular cells of cartilage canals in the developing mouse epiphysis. Am J Anat 180: 237242
  • Cole AA, Wezeman FH. 1987b. Morphometric analysis of cartilage canals in the developing mouse epiphysis. Acta Anat 128: 9397
  • Daoust R. 1965. Histochemical localization of enzyme activities by substrate film methods: ribonucleases, deoxyribonucleases, proteases, amylase and hyaluronidase. Int Rev Cytol 18: 191221.
  • Delgado-Baeza E, Giménez-Ribotta M, Miralles-Flores C, Nieto-Chaguaceda A, Santos-Alvarez I. 1991a. Morphogenesis of cartilage canals: experimental approach in the rat tibia. Acta Anat 142: 132137.
  • Delgado-Baeza E, Giménez-Ribotta M, Miralles-Flores C, Nieto-Chaguaceda A, Santos-Alvarez I. 1991b. Relationship between the cartilage canal and the perichondrium in the rat proximal tibial epiphysis. Acta Anat 141: 3135.
  • Engsig MT, Chen Q-J, Vu TH, Pedersen A-C, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse J-M. 2000. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151: 879889.
  • Eyre DR, Wu J-J. 1995. Collagen structure and cartilage matrix integrity. J Rheumatol (Suppl) 21: 8285.
  • Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623628.
  • Handler M, Yurchenco PD, Iozzo RV. 1997. Developmental expression of perlecan during murine embryogenesis. Dev Dyn 210: 130145.
  • Harris ED, Krane SD. 1972. An endopeptidase from rheumatoid synovial tissue culture. Biochim Biophys Acta 258: 566576.
  • Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL. 1990. Human neutrophil collagenase: a distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 265: 1142111424.
  • Hipps DS, Hembry RM, Docherty AJ, Reynolds JJ, Murphy G. 1991. Purification and characterization of human 72kDa gelatinase (type IV collagenase). Biol Chem Hoppe-Seyler 372: 287296.
  • Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99: 8192.
  • Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. 1996. Biochemical characterization of human collagenase-3. J Biol Chem 271: 15441550.
  • Lee ER, Lamplugh L, Leblond CP, Mordier S, Magny M-C, Mort JS. 1998. Immunolocalization of the cleavage of the aggrecan core protein at the Asn341-Phe342 bond, as an indicator of the location of the metalloproteinases active in the lysis of the rat growth plate. Anat Rec 252: 117132.
  • Lee ER, Murphy G, El-Alfy M, Davoli MA, Lamplugh L, Docherty AJ, Leblond CP. 1999. Active gelatinase B is identified by histozymography in the cartilage resorption sites of developing long bones. Dev Dyn 215: 190205.
  • Lee ER, Lamplugh L, Mort JS, Murphy G, Leblond CP. 2000. Neoepitope antibodies and immunolocalization techniques reveal that active gelatinase B is involved in the lysis required for the development of the rat long bone epiphysis. J Bone Miner Res 15: S349.
  • Lee ER, Lamplugh L, Davoli MA, Beauchemin, Chan K, Mort JS, Leblond CP. 2001. Enzymes active in the areas undergoing cartilage resorption during development of the secondary ossification center in the tibiae of rats aged 0–21 days: I. Two groups of proteinases cleave the core protein of aggrecan. Dev Dyn (this issue).
  • Lelongt B, Trugnan G, Murphy G, Ronco PM. 1997. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J Cell Biol 136: 13631373.
  • Levene C. 1964. The patterns of cartilage canals. J Anat 98: 515538.
  • McLean I, Nakane PI. 1974. Periodate-lysine-paraformaldehyde fixative. A new fixative for immunoelectron microscopy. J Histochem Cytochem 22: 10771083.
  • Miller EJ, Harris EC, Chung E, Finch JE, McCroskery PA, Butler WT. 1976. Cleavage of type II and III collagen with mammalian collagenase: site of cleavage and primary structure at the NH2-terminal portion of the smaller fragment released from both collagens. Biochemistry 15: 787792.
  • Mitchell PG, Magna HA, Reeves LM Lopresti-Morrow LL, Yocum SA, Rosner FJ, Geoghegan KF, Hambor JE. 1996. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97: 761768.
  • Murphy G, Crabbe T. 1995. Gelatinases A and B. Methods Enzymol 248: 470484.
  • Murphy G, Knäuper V. 1997. Relating matrix metalloproteinase structure to function: Why the “Hemopexin” domain? Matrix Biol 15: 511518.
  • Murphy G, Cawston TE, Galloway WA, Barnes MJ, Bunning RAD, Mercer E, Reynolds JJ, Burgeson RE. 1981. Metalloproteinases from rabbit bone culture medium degrades types IV and V collagens, laminin, and fibronectin. Biochem J 199: 807811.
  • Murphy G, Reynolds JJ, Bretz U, Baggiolini M. 1982. Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. Biochem J 203: 209221.
  • Murphy G, Ward R, Hembry RM, Reynolds JJ, Kuhn K, Tryggvason K. 1989. Characterization of gelatinase from pig polymorphonuclear leucocytes. Biochem J 258: 463472.
  • Murphy G, Cockett MI, Ward RV, Docherty JP. 1991a. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. Biochem J 277: 277279.
  • Murphy G, Houbrechts A, Cockett MI, Williamson RA, O'Shea M, Docherty AJP. 1991b. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30: 80978102.
  • Niyibizi C, Chan R, Wu J-J, Eyre D. 1994. A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen. Biochem Biophys Res Commun 202: 328333.
  • Oliver GW, Leferson JD, Stetler-Stevenson WG, Kleiner DE. 1997. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal Biochem 244: 161166.
  • Pourmotabbed T, Solomon TL, Hasty KA, Mainaardi CL. 1994. Characteristics of 92 kDa type IV collagenase/gelatinase produced by granulocytic leukemia cells: structure, expression of cDNA in E. coli and enzymatic properties. Biochim Biophys Acta 1204: 97107.
  • Quinn CO, Scott DK, Brinckerhoff CE, Matrisian LM, Jeffrey JJ, Partridge NC. 1990. Rat collagenase. Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells. J Biol Chem 265: 2234222347.
  • Sato H, Okada Y, Seiki M. 1997. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thromb Haemost 78: 497500.
  • Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411422.
  • Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJP, Cockett MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G. 1993. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry 32: 43304337.
  • Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Yihai C, Tryggvason K. 2000. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 97: 40524057.